NO982500D0 - FremgangsmÕte for fremstilling av S(-)natrium 2-(4-isobutylfenyl) propionat med h°y enantiomer renhet, samt forbindelsen dihydratet derav som sÕdan - Google Patents

FremgangsmÕte for fremstilling av S(-)natrium 2-(4-isobutylfenyl) propionat med h°y enantiomer renhet, samt forbindelsen dihydratet derav som sÕdan

Info

Publication number
NO982500D0
NO982500D0 NO982500A NO982500A NO982500D0 NO 982500 D0 NO982500 D0 NO 982500D0 NO 982500 A NO982500 A NO 982500A NO 982500 A NO982500 A NO 982500A NO 982500 D0 NO982500 D0 NO 982500D0
Authority
NO
Norway
Prior art keywords
isobutylphenyl
sodium
propionate
enantiomeric purity
preparation
Prior art date
Application number
NO982500A
Other languages
English (en)
Other versions
NO982500L (no
NO305696B1 (no
Inventor
Bernard John Armitage
Paul Frederick Coe
John Francis Lampard
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26298899&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO982500(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB919110342A external-priority patent/GB9110342D0/en
Priority claimed from GB919112058A external-priority patent/GB9112058D0/en
Publication of NO982500L publication Critical patent/NO982500L/no
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of NO982500D0 publication Critical patent/NO982500D0/no
Publication of NO305696B1 publication Critical patent/NO305696B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
NO982500A 1991-05-13 1998-06-02 FremgangsmÕte for fremstilling av S(-)natrium 2-(4-isobutylfenyl) propionat med h°y enantiomer renhet NO305696B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919110342A GB9110342D0 (en) 1991-05-13 1991-05-13 Therapeutic agent
GB919112058A GB9112058D0 (en) 1991-06-05 1991-06-05 Therapeutic agent
PCT/EP1992/001025 WO1992020334A1 (en) 1991-05-13 1992-05-04 Pharmaceutical composition comprising ibuprofen salt

Publications (3)

Publication Number Publication Date
NO982500L NO982500L (no) 1993-11-12
NO982500D0 true NO982500D0 (no) 1998-06-02
NO305696B1 NO305696B1 (no) 1999-07-12

Family

ID=26298899

Family Applications (2)

Application Number Title Priority Date Filing Date
NO933740A NO304678B1 (no) 1991-05-13 1993-11-12 S(-)natrium 2-(4-isobutylfenyl)-propionat med hoey renhet og terapeutiske preparater inneholdende dette
NO982500A NO305696B1 (no) 1991-05-13 1998-06-02 FremgangsmÕte for fremstilling av S(-)natrium 2-(4-isobutylfenyl) propionat med h°y enantiomer renhet

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO933740A NO304678B1 (no) 1991-05-13 1993-11-12 S(-)natrium 2-(4-isobutylfenyl)-propionat med hoey renhet og terapeutiske preparater inneholdende dette

Country Status (32)

Country Link
US (3) US6525214B1 (no)
EP (1) EP0584108B1 (no)
JP (1) JP3326174B2 (no)
KR (1) KR100198044B1 (no)
CN (1) CN1068305C (no)
AT (1) ATE195417T1 (no)
AU (1) AU658415B2 (no)
BG (1) BG61676B1 (no)
CA (1) CA2102530C (no)
CZ (1) CZ281717B6 (no)
DE (1) DE69231359T2 (no)
DK (1) DK0584108T3 (no)
EG (1) EG20309A (no)
ES (1) ES2148175T3 (no)
FI (1) FI109994B (no)
GE (1) GEP20002013B (no)
GR (1) GR3034780T3 (no)
HU (1) HU219242B (no)
IE (1) IE921393A1 (no)
IL (1) IL101818A (no)
MX (1) MX9202215A (no)
MY (1) MY110267A (no)
NO (2) NO304678B1 (no)
NZ (1) NZ242640A (no)
PT (1) PT100476B (no)
RO (1) RO118371B1 (no)
RU (1) RU2145219C1 (no)
SK (1) SK279279B6 (no)
TW (1) TW304940B (no)
UA (1) UA34430C2 (no)
WO (1) WO1992020334A1 (no)
YU (1) YU48928B (no)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0584108B1 (en) * 1991-05-13 2000-08-16 The Boots Company PLC Pharmaceutical composition comprising ibuprofen salt
US5248813A (en) * 1992-10-14 1993-09-28 Ethyl Corporation Enantiomeric resolution
US5260482A (en) † 1992-10-14 1993-11-09 Ethyl Corporation Enantiomeric resolution
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
DE59209706D1 (de) * 1992-12-01 1999-07-08 Spirig Ag S(+)-Ibuprofen enthaltende Arzneimittel
CA2150355C (en) * 1992-12-02 2008-03-11 Robert Hardy Process of resolving phenylpropionic acids using alpha-methylbenzylamine
SI9300470A (en) * 1993-09-10 1995-04-30 Lek Tovarna Farmacevtskih Inclusion complexes of optically active and racemic ibuproxan with cyclodextrin derivates,process for their preparation,pharmaceutical preparations comprising the same and their use
EP0667149A1 (en) * 1994-02-14 1995-08-16 E-PHARMA TRENTO S.p.A. Ibuprofen based effervescent composition
IT1270239B (it) * 1994-06-17 1997-04-29 Zambon Spa Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
GB9603699D0 (en) * 1996-02-21 1996-04-17 Boots Co Plc Therapeutic composition
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
US20050063998A1 (en) * 1999-10-26 2005-03-24 Francois Marc Karel Jozef Oral solution containing galantamine and a sweetening agent
FR2800276B1 (fr) * 1999-10-27 2004-08-20 Palbian Snc Composition et medicament, notamment anti-inflammatoire, constitue de ladite composition
NZ508292A (en) * 1999-11-24 2002-08-28 Mcneil Ppc Inc Treatment of migraine symptoms with ibuprofen and salts thereof
PT1321140E (pt) * 2000-08-25 2005-06-30 Kowa Co Solucoes de ibuprofeno para o enchimento de capsulas e preparacoes de capsula
JP2002069030A (ja) * 2000-08-30 2002-03-08 Kyowa Hakko Kogyo Co Ltd ナトリウム２−｛４−［（２−オキソシクロペンチル）メチル］フェニル｝プロピオネート２水和物の製造法
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
US6440983B1 (en) * 2000-12-21 2002-08-27 Mary Theresa Frank-Kollman Compositions and methods for relieving headache symptoms in aspirin-sensitive headache sufferers
AU2002258013A1 (en) * 2001-04-10 2002-10-28 Fakhreddin Jamali Animal model for evaluating analgesics
JP2003026634A (ja) * 2001-07-17 2003-01-29 Mercian Corp プラバスタチンナトリウム塩の製造方法
AU2002341984B2 (en) * 2001-10-04 2008-01-03 Macrochem Corporation Ibuprofen salt emulsifiers and cream formulations containing same
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
WO2004006890A1 (en) 2002-07-15 2004-01-22 Alcon, Inc. Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use
WO2004006957A1 (en) * 2002-07-15 2004-01-22 Alcon, Inc. Pharmaceutical compositions for otic use
JP4454019B2 (ja) * 2002-07-15 2010-04-21 アルコン，インコーポレイテッド 眼薬送達のための生体侵食性フィルム
CL2003002653A1 (es) * 2002-12-18 2005-04-22 Wyeth Corp Composicion farmaceutica que comprende (a) un antiinflamatorio no esteroidal (nsaid), preferentemente ibuprofeno, (b) un descongestionante, preferentemente pseudoefedrina y (c) un antihistaminico, preferentemente clorfeniramina; metodo para su prepar
US20040228804A1 (en) * 2003-05-16 2004-11-18 Jones Alonzo H. Nasal administration of xylitol to a non-human mammal
CZ295151B6 (cs) * 2004-02-20 2005-06-15 I. Q. A., A. S. Stabilní, chuťově přijatelné sirupy obsahující ibuprofen a způsob jejich přípravy
GB2411833A (en) * 2004-03-08 2005-09-14 Skin Salveation Ltd Composition for use in the treatment of dry skin conditions
WO2005121061A1 (en) * 2004-06-07 2005-12-22 Strides Research And Specialty Chemicals Limited Novel process for producing ibuprofen sodium dihydrate
BRPI0418885A (pt) * 2004-06-07 2007-11-27 Strides Arcolab Ltd composição farmacêutica contendo uma solução estável e clara de fármaco antiinflamatória em cápsula de gelatina mole e processo para a produção da mesma
EP1804772B1 (en) * 2004-08-12 2011-10-05 Reckitt Benckiser Healthcare (UK) Limited Granules comprising a non-steroidal anti-inflammatory drug and a sugar alcohol made by melt extrusion
US8067451B2 (en) * 2006-07-18 2011-11-29 Horizon Pharma Usa, Inc. Methods and medicaments for administration of ibuprofen
CA2615496C (en) * 2005-07-18 2014-11-18 Horizon Therapeutics, Inc. Medicaments containing famotidine and ibuprofen and administration of same
US20080020040A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Unit dose form for administration of ibuprofen
US8067033B2 (en) * 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
CL2007002425A1 (es) 2006-08-22 2008-06-27 Albermarle Corp Procedimiento de preparacion controlado de sal sodica de ibuprofeno de tamano de particula mediano; y dichas particulas de sal sodica.
FI20080348A0 (fi) * 2008-02-15 2008-05-09 Atacama Labs Oy Uudenlainen farmaseuttinen formulaatio
CN101820863A (zh) * 2007-10-10 2010-09-01 马林克罗特贝克公司 直接可压制的高功能性颗粒状微晶纤维素基赋形剂、其制备方法和用途
US20100055180A1 (en) * 2007-10-10 2010-03-04 Mallinckrodt Baker, Inc. Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
WO2011001228A1 (en) * 2008-08-14 2011-01-06 Shasun Chemicals And Drugs Limited Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
CA2749941C (en) 2008-09-10 2018-04-24 Biochemics, Inc. Ibuprofen for topical administration
MX349176B (es) 2008-09-22 2017-07-14 Biochemics Inc Suministro transdermico de farmaco empleando un osmolito y un agente vasoactivo.
EP2351729B1 (en) * 2008-10-29 2014-01-22 Mitsubishi Gas Chemical Company, Inc. Process for production of optically active organic carboxylic acid
AU2014200704C1 (en) * 2009-06-22 2018-12-06 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
AU2015264861C1 (en) * 2009-06-22 2017-11-16 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
KR101429331B1 (ko) * 2009-06-22 2014-08-11 와이어쓰 엘엘씨 이부프로펜 나트륨 정제 및 이부프로펜 나트륨을 포함하는 제약 조성물의 제조 방법
CA2784827C (en) * 2009-12-16 2018-10-23 Shasun Pharmaceuticals Limited Composition of dexibuprofen transdermal hydrogel
CN102557918B (zh) * 2011-11-28 2013-08-21 海南永田药物研究院有限公司 一种布洛芬钠化合物及其制法
WO2013154511A1 (en) * 2012-04-13 2013-10-17 Mahmut Bilgic Film tablet formulations comprising dexibuprofen
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
CN102992997A (zh) * 2012-11-20 2013-03-27 北京阜康仁生物制药科技有限公司 右布洛芬的新药用盐
CN104744236A (zh) * 2013-12-26 2015-07-01 鲁南贝特制药有限公司 一种右旋布洛芬的精制方法
EP2965746B1 (en) 2014-07-10 2019-03-13 Santa Farma Ilaç Sanayi A.S. An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
JPS5826744B2 (ja) 1975-12-24 1983-06-04 ヒサミツセイヤク カブシキガイシヤ シンキナプロピオンサン エステルユウドウタイノセイゾウホウ
JPS53112837A (en) 1977-03-11 1978-10-02 Mitsui Toatsu Chem Inc Method of isolation of alpha-phenylpropionic acid compound
EP0070714B1 (en) 1981-07-20 1986-05-07 The Upjohn Company Use of ibuprofen or flurbiprofen for the manufacture of a medicament for treating respiratory disorders
GB8528195D0 (en) 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
US4873231A (en) 1986-04-08 1989-10-10 Smith Walton J Decreasing the toxicity of an ibuprofen salt
DE3621036A1 (de) * 1986-06-24 1988-01-07 Merckle Gmbh Fluessige ibuprofen-zubereitungen
US4684666A (en) 1986-08-19 1987-08-04 Haas Pharmaceuticals, Inc. Stabilized liquid analgesic compositions
DE3669103D1 (de) 1986-11-14 1990-04-05 Puetter Medice Chem Pharm Ibuprofen enthaltendes arzneimittel.
GB8701392D0 (en) 1987-01-22 1987-02-25 Boots Co Plc Therapeutic agents
US4980375A (en) 1987-07-10 1990-12-25 Sterling Drug Inc. Onset-hastened/enhanced antipyretic response
IT1222013B (it) 1987-07-10 1990-08-31 Chimica Profarmaco Spa Ind Processo di risoluzione ottica di acido 2 (6 metossi 2 naftil) propionico
US4851444A (en) 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
US4861797A (en) 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
US4859704A (en) 1987-10-15 1989-08-22 Oratech Pharmaceutical Development Corporation Water soluble ibuprofen compositions and methods of making them
IT1217988B (it) 1988-01-28 1990-03-30 Ind Chimica Profarmaco Spa Procedimento per la risoluzione ottica di un pacemo
DE3814887C1 (no) * 1988-05-02 1989-09-21 Medice Chem.-Pharm. Fabrik Puetter Gmbh & Co Kg, 5860 Iserlohn, De
US4831147A (en) 1988-07-05 1989-05-16 The Dow Chemical Company Resolution of enantiomers of herbicidal 2-(4-aryloxyphenoxy) propionates by chiral two-phase extraction
CH677606A5 (no) 1988-07-12 1991-06-14 Aesculapius Pharma Sa
DE3838431A1 (de) 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
AU643210B2 (en) 1989-05-16 1993-11-11 Medice Chem.-Pharm. Fabrik Putter Gmbh & Co. Kg Process for preparing optically active 2-aryl-alkanoic acids, in particular 2-ayrl-propionic acids
US5100918A (en) 1989-05-25 1992-03-31 Sterling Drug, Inc. Prevention or treatment of sunburn using the S(+) isomer of ibuprofen
US4946997A (en) 1989-06-07 1990-08-07 Merck & Co., Inc. Racemization of a carboxylic acid
DE3922441A1 (de) * 1989-07-07 1991-01-17 Pharmatrans Sanaq Ag Ibuprofen- und s-(+)-ibuprofen-zubereitungen und verfahren zu ihrer herstellung
GB8920693D0 (en) * 1989-09-13 1989-10-25 Nicholas Kiwi Pty Ltd Non-effervescent ibuprofen compositions
US5200558A (en) 1989-10-17 1993-04-06 Merck & Co., Inc. S(+)-ibuprofen-L-amino acid and S(+)-ibuprofen-D-amino acid as onset-hastened enhanced analgesics
US4994604A (en) 1990-01-10 1991-02-19 Merck & Co., Inc. Formation and resolution of ibuprofen lysinate
US5015764A (en) * 1990-06-18 1991-05-14 Ethyl Corporation Preparation of optically active aliphatic carboxylic acids
US5164398A (en) 1991-04-01 1992-11-17 Merck & Co., Inc. Ibuprofen-antitussive combinations
EP0584108B1 (en) * 1991-05-13 2000-08-16 The Boots Company PLC Pharmaceutical composition comprising ibuprofen salt
US5189208A (en) 1991-07-01 1993-02-23 Ethyl Corporation Ibuprofen resolution
US5302751A (en) 1992-01-21 1994-04-12 Ethyl Corporation Profen resolution
US5235095A (en) 1992-01-24 1993-08-10 Ethyl Corporation Preparation of optically active aliphatic carboxylic acids
US5235100A (en) 1992-01-24 1993-08-10 Ethyl Corporation Preparation of optically active aliphatic carboxylic acids
US5220053A (en) 1992-01-24 1993-06-15 Ethyl Corporation Preparation of optically active aliphatic carboxylic acids
US5235101A (en) 1992-01-24 1993-08-10 Ethyl Corporation Preparation by flotation of optically active aliphatic carboxylic acids
US5248213A (en) 1992-01-27 1993-09-28 Plastek Industries, Inc. Seal for roll-on dispenser
US5278337A (en) 1992-10-14 1994-01-11 Ethyl Corporation Enantiomeric resolution of aryl-substituted aliphatic carboxylic acids
US5256816A (en) 1992-10-14 1993-10-26 Ethyl Corporation Enantiomeric resolution
US5260482A (en) 1992-10-14 1993-11-09 Ethyl Corporation Enantiomeric resolution
US5248813A (en) 1992-10-14 1993-09-28 Ethyl Corporation Enantiomeric resolution

Also Published As

Publication number Publication date
CZ240593A3 (en) 1994-03-16
NO982500L (no) 1993-11-12
JPH06507159A (ja) 1994-08-11
MY110267A (en) 1998-03-31
FI109994B (fi) 2002-11-15
CA2102530A1 (en) 1992-11-14
WO1992020334A1 (en) 1992-11-26
NO305696B1 (no) 1999-07-12
HUT67034A (en) 1995-01-30
KR100198044B1 (ko) 1999-06-15
NZ242640A (en) 1993-11-25
YU50292A (sh) 1995-03-27
AU1671192A (en) 1992-12-30
JP3326174B2 (ja) 2002-09-17
RU2145219C1 (ru) 2000-02-10
ES2148175T3 (es) 2000-10-16
EG20309A (en) 1998-10-31
BG61676B1 (bg) 1998-03-31
SK125993A3 (en) 1994-04-06
NO304678B1 (no) 1999-02-01
EP0584108B1 (en) 2000-08-16
CN1068734A (zh) 1993-02-10
MX9202215A (es) 1992-11-01
GR3034780T3 (en) 2001-02-28
US5696165B1 (en) 2000-12-05
ATE195417T1 (de) 2000-09-15
RO118371B1 (ro) 2003-05-30
SK279279B6 (sk) 1998-09-09
AU658415B2 (en) 1995-04-13
FI934964L (fi) 1993-11-10
NO934102L (no) 1993-11-12
US6525214B1 (en) 2003-02-25
HU219242B (en) 2001-03-28
FI934964A0 (fi) 1993-11-10
DE69231359D1 (de) 2000-09-21
BG98214A (bg) 1994-07-29
US6242000B1 (en) 2001-06-05
CZ281717B6 (cs) 1996-12-11
YU48928B (sh) 2002-12-10
IL101818A (en) 1999-08-17
NO934102D0 (no) 1993-11-12
EP0584108A1 (en) 1994-03-02
PT100476A (pt) 1993-08-31
UA34430C2 (uk) 2001-03-15
GEP20002013B (en) 2000-04-10
DE69231359T2 (de) 2001-02-08
DK0584108T3 (da) 2000-10-09
HU9303220D0 (en) 1994-03-28
US5696165A (en) 1997-12-09
IE921393A1 (en) 1992-11-18
TW304940B (no) 1997-05-11
IL101818A0 (en) 1992-12-30
PT100476B (pt) 1999-09-30
CA2102530C (en) 2003-07-29
CN1068305C (zh) 2001-07-11

Similar Documents

Publication Publication Date Title
NO982500L (no) FremgangsmÕte for fremstilling av S(-)natrium 2-(4-isobutylfenyl) propionat med h°y enantiomer renhet, samt forbindelsen dihydratet derav som sÕdan
RU93058389A (ru) Фармацевтическая композиция, содержащая s(-)-2-(4-изобутилфенил)пропионат натрия, способ ее получения, применение композиции, способы получения натриевой соли энантиомера 2-(4-изобутилфенил)пропионовой кислоты, s(-)-2-(4-изобутилфенил)пропионата натрия дигидрат
RU95112575A (ru) Соль арилпропионовой кислоты, способ ее получения и фармацевтическая композиция
EP0318377A3 (en) Enantiomeric derivatives of amino acids, process for their preparation and their pharmaceutical applications
DE3475691D1 (en) Injectable solution for the treatment of inflammations
KE3820A (en) Pharmaceutical preparations for topical application which contain salts of alkanecarboxylic acids,novel carboxylic acid salts and the production thereof
SI0935961T1 (sl) Soli (R)-2-(3-benzoilfenil)propionske kisline in farmacevtski pripravki, ki jih vsebujejo
NO863935D0 (no) Fremgangsmaate for fremstilling av terapeutiske preparater inneholdende 2-(2-fluor-4-bifenylyl)propionsyre.
EA199600028A3 (ru) Оральная фармацевтическая композиция, содержащая s (+)-ибупрофен, и способ её получения
DE69415018D1 (de) Oralanzuwendende flüssige arzneizubereitung enthaltend 2-(4-isobutylphenyl)propionsäure
AU8268591A (en) Codeine salt of a substituted carboxylic acid, processes for the preparation thereof, its use and pharmaceutical compositions
PT84399A (en) Process for the preparation of pharmaceutical compositions containing sodium 2-(2,6-dichloroanilino) phenylacetate
GR3015937T3 (en) Salts of the 2-(2,6-dichloroanilino)-phenylacetic acid, process for their preparation and their application as pharmaceutical preparations for topical use.
ES8501760A1 (es) Procedimiento para la preparacion de 1-(1,3-benzodioxol-5-il)-2-pirrolidinona.
ES8300747A1 (es) Procedimiento para la preparacion de derivados de acido in- dolacetico
ZA824649B (en) New optically active dipeptides, process for their preparation and pharmaceutical products containing these compounds
IT1271432B (it) Sali dell'acido s(+) 2-(3-benzoilfenil) propionico con basi organiche chirali, composizioni farmaceutiche che li contengono e procedimento per la loro preparazione.
IT1270699B (it) Sali dell'acido s(+)-2-(4-isobutilfenil)propionico con mono-, di- e trialcanolammine
ZA893509B (en) Novel 6-phenoxymethyl-4-hydroxytetrahydrophyran-2-ones and 6-thiophenoxymethyl-4-hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives,salts and esters,processes for the preparation of these compounds,their use as pharmaceuticals,pharmaceutical preparations and novel phenols and thiophenols

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees